Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The sourcing risk still applies
Phase II clinical trials in humans showed that AOD-9604 produced statistically significant weight loss compared to placebo over 12 weeks
PubMed laboratory research record [PMID: 8103805] PubMed record related to this compound for laboratory literature review
Each injection is prepared using pharmaceutical-grade ingredients in sterile, single-use vials under clinical conditions
Supplied as a 50 mg lyophilized research compound with full COA traceability
Elevating Healthcare Professional Education A common problem faced by PA patients is the adherence to a rigid, infrequent injection schedule (typically 1mg every 2-3 months)
US$ 27.96
US$ 21.44
US$ 24.02
US$ 26.86
US$ 29.64
US$ 20.73
